Stockscreener 앱 받기
14.27
8.35%
1.10
시간 외 거래:
14.30
0.03
+0.21%
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
Aurinia Pharmaceuticals Reports Strong Q3 2025 Earnings - TipRanks
Aurinia Pharmaceuticals Inc. Increases Revenue Guidance for the Year 2025 - MarketScreener
Aurinia Pharmaceuticals stock hits 52-week high at 13.6 USD By Investing.com - Investing.com Canada
Aurinia: Q3 Earnings Snapshot - Norwalk Hour
Aruinia stock gains after Q3 earnings beat (AUPH:NASDAQ) - Seeking Alpha
Aurinia Pharmaceuticals stock hits 52-week high at 13.6 USD - Investing.com
Aurinia Pharmaceuticals Boosts 2025 Sales Guidance Amid Strong Q3 Performance - TipRanks
Aurinia Pharmaceuticals Doubles Profit As Lupkynis Sales Jump - Finimize
Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Aurinia Pharmaceuticals Inc $AUPH Shares Bought by Hussman Strategic Advisors Inc. - MarketBeat
Aurinia Pharmaceuticals Q3 profit doubles on strong LUPKYNIS sales, raises FY sales view - MarketScreener
Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Bluefield Daily Telegraph
Why Aurinia Pharmaceuticals Inc. is moving today2025 Trading Recap & Daily Entry Point Trade Alerts - newser.com
Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025 - BioSpace
Is Aurinia Pharmaceuticals Inc. stock positioned well for digital economyTrend Reversal & Safe Capital Growth Trade Ideas - newser.com
FDA CDER Head Janet Tidmarsh Removed Amid Aurinia Pharmaceuticals Lawsuit Alleging Misconduct - geneonline.com
FDA Official Quits As Aurinia Sues Over 'Personal Vendetta' - Law360
FDA’s top drug regulator sued by drug company, resigns amid conduct probe - The Hill
Aurinia Pharmaceuticals Reportedly Files Lawsuit Against US FDA Official - MarketScreener
US FDA's drug division chief resigns amid ethics concerns and lawsuit - Reuters
FDA’s Top Drug Regulator Resigns, Agency Cites Personal Conduct - Bloomberg.com
Strategies to average down on Aurinia Pharmaceuticals Inc.2025 Analyst Calls & Consistent Growth Equity Picks - newser.com
Will Aurinia Pharmaceuticals Inc. stock recover faster than marketGlobal Markets & Weekly Stock Breakout Alerts - newser.com
Aurinia Pharmaceuticals Inc expected to post earnings of 16 cents a shareEarnings Preview - TradingView
Key metrics from Aurinia Pharmaceuticals Inc.’s quarterly data2025 Bull vs Bear & Expert-Curated Trade Recommendations - newser.com
Wall Street Breakfast Podcast: FDA Executive Controversy (undefined:AUPH) - Seeking Alpha
Is Aurinia Pharmaceuticals Inc. building a consolidation baseJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com
Aurinia Pharmaceuticals To Report Q3 Results, Provide Update On Recent Business Progress On November 4 - TradingView
Published on: 2025-11-03 05:10:28 - newser.com
Can Aurinia Pharmaceuticals Inc. stock reach $100 price targetRecession Risk & Low Drawdown Investment Ideas - newser.com
PRESS DIGEST-Wall Street JournalNovember 3 - facilitiesmanagement-now.com
Analyzing drawdowns of Aurinia Pharmaceuticals Inc. with statistical toolsWeekly Trend Summary & Long-Term Capital Growth Ideas - newser.com
Is Aurinia Pharmaceuticals Inc. reversing from oversold territoryMarket Movement Recap & Free Weekly Watchlist of Top Performers - newser.com
Using data models to predict Aurinia Pharmaceuticals Inc. stock movementDip Buying & Free Reliable Trade Execution Plans - newser.com
Combining price and volume data for Aurinia Pharmaceuticals Inc.Weekly Trading Summary & Daily Profit Focused Stock Screening - newser.com
F.D.A. Drug Unit Chief Resigns, and Is Sued by Drug Company - The New York Times
Top FDA official Tidmarsh resigns after comments on kidney drug, HHS probe - Seeking Alpha
FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - Stocktwits
Is Aurinia Pharmaceuticals Inc. (IKAP) stock undervalued historicallyMarket Growth Summary & Free High Return Stock Watch Alerts - newser.com
FDA Official Steps Down, Sued by DrugmakerWSJ - The Wall Street Journal
Will breakout in Aurinia Pharmaceuticals Inc. lead to full recoveryWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - newser.com
What analysts say about Aurinia Pharmaceuticals Inc IKAP stockMACD Trading Signals & Double Digit Wealth Tips - earlytimes.in
Is It Time to Lock in Profits on Standard Glass Lining Technology Limited StockSupport Zone Identification & Backtest Your Strategy Before You Risk Money - earlytimes.in
Visualizing Aurinia Pharmaceuticals Inc. stock with heatmaps2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com
Chart overlay techniques for tracking Aurinia Pharmaceuticals Inc.Market Performance Summary & Community Consensus Picks - newser.com
1.45%
0.86%
자본화:
|
볼륨(24시간):